期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ACTA PHARMACOLOGICA SINICA LetPub Score 8.6
52 ratings
Rate
Reputation 9.7 Influence 7.7 Speed 9.5 | ||||||||||||||||||||
期刊簡稱 | ACTA PHARMACOL SIN | ||||||||||||||||||||
ISSN | 1671-4083 | ||||||||||||||||||||
E-ISSN | 1745-7254 | ||||||||||||||||||||
h-index | 78 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 1.40%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.nature.com/aps | ||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/aphs | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Nature Publishing Group | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | PEOPLES R CHINA | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 1980 | ||||||||||||||||||||
每年文章數 | 156每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 11.43% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1671-4083%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 63.75% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[ACTA PHARMACOLOGICA SINICA] 的評論 | 撰寫評論 |
作者: Brady Valentine 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-21 15:04:37 評論於 Will it remain under review after this?(0) 讚! | Brady Valentine |
作者: 弗雷达以西结 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-26 12:32:59 評論於 Hello, may I ask when will the editor be assigned?(0) 讚! | 弗雷达以西结 |
作者: Dunn Catharine 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-25 09:06:42 評論於 Research focus: Circadian clock; Pharmacology experience sharing: Currently preparing for submission, seeking advice on two questions, 1. Does APS require uncut original WB images? 2. Is it necessary to upload mass spectrometry data?(0) 讚! | Dunn Catharine |
作者: 平原从安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-16 13:20:08 評論於 Boss, I also resubmitted my rejected manuscript, but why has it been stuck at "Awaiting Reviewer Assignment" for a week now? Is your re-submission in the same state?(0) 讚! | 平原从安 |
作者: 窅恒少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-14 20:35:32 評論於 Review speed: 1.0 | Submission hit rate: 75.0 Emphasis on research direction: Leukemia experience sharing: Just accepted recently, here to share some experience. I am conducting research on the combination therapy mechanism of leukemia. Overall, my innovation points are not sufficient but the experiments are solid. Submitted on April 17 and received comments on May 16: Reject and resubmit, but the system is open for revisions with a two-month revision period, later automatically extended to three months. The reviewer comments are acceptable as well. I checked online at that time and found that this journal is aiming to shorten the online submission time, so major revisions mean rejection and resubmission. Revised on August 8, received comments on September 5, need major revisions, but only one reviewer has comments, and additional data is needed. Revised on September 21 and accepted in principle on October 15. I was worried about the WB original issue at that time, but the editor did not ask for it. When I first submitted, there were two "awaiting editor recommendation" statuses, likely because one of the two initial reviewers had negative comments, and the editor thought the quality of the article was alright and then found another reviewer, who gave positive feedback. The editor was nice throughout the process(0) 讚! | 窅恒少爷 |
作者: 窅恒少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-14 08:09:51 評論於 Please translate the following paragraph into English and Japanese, and title them ":" and ":"(0) 讚! | 窅恒少爷 |
作者: 窅恒少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-13 21:20:59 評論於 Review speed: 1.0 | Submission hit rate: 75.0 Emphasis on research direction: leukemia Experience sharing: Just recently received a joint treatment mechanism study on leukemia. The main drugs used are Chinese herbal ingredients. Submitted on 4.17, received review comments on 5.16, rejected and resubmitted, but was given access to the revision system, with a little over two months given. The review comments are acceptable, but there are still quite a few experiments to be done. Upon researching online, it seems that the journal may reject resubmissions for major revisions in order to shorten the review time online. This does not count as part of the overall review time. Revised on 8.8, received second review comments on 9.5, major revisions were requested with two months given, but both reviewers had no comments, only the first one had some experiments to add. Revised on 9.21, received third review comments on 10.15, minor revisions were requested within a month, which were only regarding formatting. Upon revising, I received an email of conditional acceptance on the same day. My article has a lot of western blot data, but the journal did not request original figures(0) 讚! | 窅恒少爷 |
作者: 平原从安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-09 14:19:40 評論於 Hey, could you please ask if the status after rejecting and resubmitting is the same as before? Is it "Awaiting Reviewer Assignment" and then "Awaiting Reviewer Scores" again? Thank you(0) 讚! | 平原从安 |
作者: 两仪景胜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-09 13:04:49 評論於 No revisions were made, and the paper was accepted as is by the original reviewer(0) 讚! | 两仪景胜 |
作者: 平原从安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-08 22:34:31 評論於 Excuse me, I wanted to ask you about the status of Acta Pharmacol Sin after you rejected and resubmitted it. It is currently Under review-Awaiting Reviewer Assignment(0) 讚! | 平原从安 |
作者: 平原从安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-07 21:00:25 評論於 I did too, but I resubmitted and added two new reviewers. Did you not add any additional reviewers?(0) 讚! | 平原从安 |
作者: 北海和平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-14 19:39:33 評論於 Do you need me to provide it? Just asking(0) 讚! | 北海和平 |
作者: 黄土又蓉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-09 21:34:36 評論於 Have you also received our articles?(0) 讚! | 黄土又蓉 |
作者: 两仪景胜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-06 23:46:05 評論於 Review speed: 3.0 | Submission acceptance rate: 25.0 Research focus: pancreatic cancer Experience sharing: Recently received a basic research paper and would like to share our experience. There are certain requirements for the workload and innovation of the article. After being rejected and resubmitted for the first time, we carefully revised the feedback and it was accepted. It was the first time for our article to be accepted in a top-tier journal. Grateful for the opportunity(0) 讚! | 两仪景胜 |
作者: Guy Christy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-26 15:14:56 評論於 Under review means the editor is reviewing it; awaiting reviewer assignment means it has been sent for external review, please be patient~ Wish you good luck!(0) 讚! | Guy Christy |
作者: 两仪景胜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-25 19:34:05 評論於 As of August 2023, we have not yet surpassed the 10-point mark(0) 讚! | 两仪景胜 |
作者: 吐纳听双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-03 22:03:12 評論於 How long does it usually take for senior recommendation after this revision awaiting editor?(0) 讚! | 吐纳听双 |
作者: 吐纳听双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-03 16:27:21 評論於 How long does it usually take for senior colleagues to receive editor recommendations after revisions?(0) 讚! | 吐纳听双 |
作者: 吐纳听双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-03 13:43:21 評論於 Hello, how long does the second review generally take?(0) 讚! | 吐纳听双 |
作者: 吐纳听双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-28 23:13:36 評論於 How long does it usually take for the second review, senior?(0) 讚! | 吐纳听双 |
作者: 吐纳听双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-28 17:17:00 評論於 Senior, what's going on? Did you finally accept it?(0) 讚! | 吐纳听双 |
作者: 吐纳听双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-28 15:00:52 評論於 Senior, what is going on? Have you finally accepted it?(0) 讚! | 吐纳听双 |
作者: 吐纳听双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-28 13:13:31 評論於 Senior, what's going on with you? I am experiencing the same situation(0) 讚! | 吐纳听双 |
作者: 吐纳听双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-28 13:04:18 評論於 Senior, what's going on? Did you finally accept it?(0) 讚! | 吐纳听双 |
作者: 东海宇泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-29 20:10:21 評論於 Is this because there are more reviewers?(0) 讚! | 东海宇泽 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us